for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

カーディナル・ヘルス・インク

CAH.N

現在値

56.28USD

変化

-0.41(-0.72%)

出来高

742,595

本日のレンジ

55.64

 - 

56.82

52週レンジ

44.71

 - 

62.94

∙ 約20分前の相場を表示しています。

適時開示

Cardinal Health Nuclear & Precision Health Solutions Receives U.S. Food And Drug Administration Approval For New Lymphoseek Pediatric Indication

June 10 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH™ NUCLEAR & PRECISION HEALTH SOLUTIONS RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR NEW LYMPHOSEEK® PEDIATRIC INDICATION.

Cardinal Health Reports Q3 Revenue $39.3 bln

May 6 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH REPORTS THIRD-QUARTER RESULTS FOR FISCAL YEAR 2021.Q3 NON-GAAP EARNINGS PER SHARE $1.53.Q3 GAAP EARNINGS PER SHARE $0.40.Q3 REVENUE $39.3 BILLION.SEES FY NON-GAAP EARNINGS PER SHARE $5.90 TO $6.05.NARROWED FY21 EARNINGS GUIDANCE.Q3 EARNINGS PER SHARE VIEW $1.55, REVENUE VIEW $40.09 BILLION -- REFINITIV IBES DATA.CARDINAL HEALTH - THIRD-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT WAS FLAT AT $35.1 BILLION.

Cardinal Health-Launches Outcomes

April 27 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH-LAUNCHES OUTCOMES, A DIGITAL ECOSYSTEM CONNECTING PHARMACISTS, PAYERS & PHARMA COS TO MITIGATE CHALLENGES OF MEDICATION NON-ADHERENCE.

Cardinal Health Awarded Strategic National Stockpile Contract For PPE Storage And Distribution

April 13 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH AWARDED STRATEGIC NATIONAL STOCKPILE CONTRACT FOR PPE STORAGE AND DISTRIBUTION.CARDINAL HEALTH - AWARDED $57.8 MILLION CONTRACT, INCLUDING OPTIONS THAT IF EXERCISED BY U.S. HHS COULD REACH $91.6 MILLION.CARDINAL HEALTH - CONTRACT FOR STORAGE AND DISTRIBUTION OF 80,000 PALLETS OF PERSONAL PROTECTIVE EQUIPMENT TO SUPPORT STRATEGIC NATIONAL STOCKPILE.

Cardinal To Sell Cordis Business To Hellman & Friedman In About $1 Bln Deal

March 12 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH SIGNS DEFINITIVE AGREEMENT TO SELL ITS CORDIS BUSINESS TO HELLMAN & FRIEDMAN.CARDINAL HEALTH INC - DEAL FOR APPROXIMATELY $1 BILLION.CARDINAL HEALTH - DIVESTITURE OF CORDIS BUSINESS TO DECREASE MEDICAL SEGMENT PROFIT BY ABOUT $60 MILLION TO $70 MILLION ON ANNUAL RUN-RATE BASIS.CARDINAL HEALTH INC - CO WAS AUTHORIZED TO INCUR COSTS ASSOCIATED WITH PLANNED DIVESTITURE OF UP TO $125 MILLION, PRIMARILY IN ITS FISCAL YEARS 2021, 2022.CARDINAL HEALTH - TO RETAIN FULL AUTHORITY FOR LAWSUITS RELATED TO INFERIOR VENA CAVA FILTERS IN U.S., CANADA, AND LIABILITY ASSOCIATED WITH THESE MATTERS.CARDINAL HEALTH INC - EXPECTS TO RESULT IN A PRE-TAX LOSS OF UP TO $120 MILLION IN Q3 2021 FROM CORDIS BUSINESS SALE.

Cardinal Health Inc Sees FY21 Pharmaceutical Segment Revenue Growth In Mid-Single Digit Percentage - Presentation

Feb 5 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH INC SEES FY21 PHARMACEUTICAL SEGMENT REVENUE GROWTH IN MID-SINGLE DIGIT PERCENTAGE - PRESENTATION.CARDINAL HEALTH INC - SEES FY21 PHARMACEUTICAL SEGMENT PROFIT GROWTH IN LOW-SINGLE DIGIT PERCENTAGE.CARDINAL HEALTH INC - SEES FY21 MEDICAL SEGMENT REVENUE GROWTH IN HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE.CARDINAL HEALTH INC - SEES FY21 MEDICAL SEGMENT PROFIT GROWTH IN LOW TO MID-TWENTIES PERCENTAGE.

Cardinal Health Reports Q2 Non-GAAP Earnings Per Share Of $1.74

Feb 5 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH REPORTS SECOND-QUARTER RESULTS FOR FISCAL YEAR 2021.Q2 NON-GAAP EARNINGS PER SHARE $1.74.Q2 GAAP EARNINGS PER SHARE $2.13.Q2 REVENUE $41.5 BILLION VERSUS REFINITIV IBES ESTIMATE OF $41.44 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $1.44 -- REFINITIV IBES DATA.SEES FY NON-GAAP EARNINGS PER SHARE $5.85 TO $6.10.RAISED FY21 EARNINGS GUIDANCE.SECOND-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 4% TO $37.2 BILLION.PHARMACEUTICAL SEGMENT WAS ADVERSELY AFFECTED BY COVID-19 IN QUARTER.FY2021 EARNINGS PER SHARE VIEW $5.88 -- REFINITIV IBES DATA.Q2 REVENUE FOR MEDICAL SEGMENT INCREASED 7% TO $4.3 BILLION, DRIVEN BY A NET POSITIVE IMPACT FROM COVID-19.CARDINAL HEALTH - INCREASE IN Q2 REVENUE FOR MEDICAL SEGMENT DUE TO IMPACT OF PERSONAL PROTECTIVE EQUIPMENT SALES & HIGHER VOLUMES IN LAB BUSINESS.

Cardinal Health Partners With CDC To Support Vaccine Access For Pharmacies

Nov 11 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH PARTNERS WITH CDC TO SUPPORT VACCINE ACCESS FOR PHARMACIES.CARDINAL HEALTH INC - REACHED AGREEMENT WITH U.S. CDC TO ACT AS NETWORK ADMINISTRATOR IN PHASE 2 OF FEDERAL PHARMACY PARTNERSHIP STRATEGY FOR COVID-19.CARDINAL HEALTH INC - COVID-19 VACCINE WILL BE DISTRIBUTED BY CDC'S CENTRAL DISTRIBUTOR.

Cardinal Health Reports First Quarter Fiscal 2021 Results

Nov 5 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH REPORTS FIRST QUARTER FISCAL 2021 RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $1.51.Q1 GAAP LOSS PER SHARE $0.86.Q1 REVENUE $39.1 BILLION VERSUS REFINITIV IBES ESTIMATE OF $38.18 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $1.13 -- REFINITIV IBES DATA.SEES FY NON-GAAP EARNINGS PER SHARE $5.65 TO $5.95.COMPANY RAISES FY21 EARNINGS GUIDANCE.FY2021 EARNINGS PER SHARE VIEW $5.50 -- REFINITIV IBES DATA.IN Q1 OF FISCAL YEAR 2021, COMPANY INCURRED A PRE-TAX CHARGE OF $1.02 BILLION.Q1 PRE-TAX CHARGE IS IN CONNECTION WITH OPIOID LAWSUITS AND DISCUSSIONS.Q1 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5% TO $35.1 BILLION.

U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ

Aug 18 (Reuters) - :U.S. STATES SEEK $26.4 BILLION FROM DRUG COMPANIES IN OPIOID LITIGATION- WSJ.TALKS WITH U.S. STATES INVOLVE MCKESSON, AMERISOURCEBERGEN, CARDINAL HEALTH, JOHNSON & JOHNSON - WSJ.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up